Progressive Metastatic Cutaneous TFCP2::FUS Fusion-Positive Rhabdomyosarcoma: A Case Report
This case is notable because it presents a rare example of an aggressive, <i>TFCP2::FUS</i> gene fusion-positive RMS presenting with multiple cutaneous metastases, and highlights that this entity is highly resistant to multiple chemotherapies, immunotherapy, and radiation therapy.
Authors
- Shari R. Lipner (ORCID: https://orcid.org/0000-0001-5913-9304)
- Fabrizio Remotti
- Esperanza Villanueva‐Siles
- Igor Matushansky
- Dustine Reich (ORCID: https://orcid.org/0000-0001-7284-9538)
Institutions
- Montefiore Medical Center (US)
- Cornell University (US)
- Columbia University Irving Medical Center (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1159/000549909
- Primary Topic
- Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00